GPT HEALTHCARE
|
|
| BOM : 544131     NSE : GPTHEALTH     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Jun 24,2026 |
|
Price(EOD): ₹ 149.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 1,230.68 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GPT HEALTHCARE | 3% | 6.4% | -0.2% |
| APOLLO HOSPITALS ENTERPRISE | 0.7% | 1.5% | 20.9% |
| MAX HEALTHCARE INSTITUTE | 5.1% | 5.4% | -10.7% |
| FORTIS HEALTHCARE | 2.3% | 1.1% | 28% |
| ASTER DM HEALTHCARE | -0.1% | 1.3% | 39.1% |
| NARAYANA HRUDAYALAYA | 4.5% | 3.8% | 0.1% |
| GLOBAL HEALTH | 3.9% | 5.3% | 8.7% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 1.4% | 5.6% | 22.2% |
| DR LAL PATHLABS | 1.2% | 2.6% | 14.3% |
FUNDAMENTAL ANALYSIS OF GPT HEALTHCARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF GPT HEALTHCARE
 | Ratio | Standalone | |
|---|---|---|
|
P/E P/B P/S |
29.13
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 42.22 Cr
[Latest Qtr - Mar2026 - Standalone Results ] 4.57
P/B Calculated based on Book Value of Rs 269.43 Cr
[Latest Year - Mar2026 - Standalone Results ] 2.6
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2026 - Standalone Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
320% 220% -32% |
SHARE PRICE MOMENTUM OF GPT HEALTHCARE
GPT HEALTHCARE vs SENSEX
DEBT OF GPT HEALTHCARE
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.05 0.06 0.39 0.17 |
- - - - |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF GPT HEALTHCARE
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF GPT HEALTHCARE
| Standalone | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
5.17% 12.85% 24.36% 55.49% |
24.62% 12.94% -3.08% 13% |
| QtrlyTrend |
6 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
GPT HEALTHCARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 3.3% | 2.8% | 12% |
You may also like the below Video Courses
FAQ about GPT HEALTHCARE
Is GPT HEALTHCARE good for long term investment?
As on Jun 24,2026, the Fundamentals of GPT HEALTHCARE look Strong and hence it may be good for long term investment! See Financial Performance of GPT HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is GPT HEALTHCARE UnderValued or OverValued?
As on Jun 24,2026, GPT HEALTHCARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of GPT HEALTHCARE ?
As on Jun 24,2026, the Intrinsic Value of GPT HEALTHCARE is Rs. 46.83 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 35.69
Fair Value [Median EV / Sales Model] : Rs. 46.83
Fair Value [Median Price / Sales Model] : Rs. 219.81
Estimated Median Fair Value of GPT HEALTHCARE : Rs. 46.83
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.